Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Combination therapy may benefit MS patients

A combination therapy of an antibiotic and a medication used to treat multiple sclerosis may slow the progress of the disease, a study has shown.According to a preliminary study, combining daily 100 milligram doses doxycycline and interferon therapy reduced the number of brain lesions by a quarter in a group of 15 relapsing patients.Fewer lesions were visible using MRI scans, the study said, and patients also had reduced scores on a scale designed to assess disability.Only ...

Subscribe for full online access and get...

  • Full, instant access to all stories
  • Customised email alerts straight to your inbox
  • 5,000+ practice articles in our clinical archive
  • Online learning units on fundamental aspects of nursing care

Register for guest access to keep reading and get...

  • A free taste of other selected news stories
  • Daily email newsletters

Speak with a member of the team about providing Nursing Times for your whole team
Are you a student nurse? Take advantage of a discounted rate by clicking here (Graduation date required)
Already have an account? Sign in